Results 131 to 140 of about 1,942,013 (293)
Quantitative Analysis of Immune-Reactive Cells among Leukocytes Is Useful for the Diagnosis of Drug Eruptions Caused by Bexarotene. [PDF]
Chiba H +6 more
europepmc +1 more source
ABSTRACT Objectives To synthesize the evidence on the use of fluoride in the prevention of dental caries among Indigenous populations and traditional communities through a systematic literature review. Methods An electronic search was conducted in the PubMed, Embase, Web of Science, and Latin American and Caribbean Health Sciences Literature (LILACS ...
Emily Souza Silva +2 more
wiley +1 more source
A novel rare variant of the OFD1 gene was identified in a family with dental hypoplasia, facial hypoplasia, and adult‐onset multiple atypical fractures of long bones. Another variant of the OFD1 gene was found in a woman with bisphosphonate‐associated atypical femur fracture.
Marie‐Ève Boisvert +12 more
wiley +1 more source
Deep Phenotyping in ReNU Syndrome Identifies a Recognizable Age‐Dependent Clinical Trajectory
Longitudinal evaluation of 11 individuals with ReNU syndrome revealed an age‐dependent multisystem trajectory. This longitudinal description may help clinicians anticipate changing needs in feeding, growth, neurological, visual, communication, behavioral, and orthopedic care. ABSTRACT Pathogenic variants in the noncoding gene RNU4‐2 cause ReNU syndrome,
Nadja Pekkola Pacheco +14 more
wiley +1 more source
BackgroundThis study aims to evaluate the relationship between serum thymus and activation-regulated chemokine (TARC) levels with various clinicopathological conditions in patients with drug eruptions.
Morita, Eishin +13 more
core +1 more source
Key Clinical Message Pulsed dye laser (PDL) has proven effective in resolving lupus miliaris disseminatus faciei (LMDF) where drug therapies have failed with a lack of treatment consensus for LMDF, considering early PDL intervention is crucial to achieve
Afsaneh Sadeghzadeh Bazargan +5 more
doaj +1 more source
Morbilliform drug eruptions caused by trimethoprim-sulfamethoxazole. [PDF]
Takenaka D, Nishizawa T.
europepmc +1 more source

